Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic

Author:

Elghazawy Hagar1ORCID,Bakkach Joaira2,Zaghloul Mohamed S3,Abusanad Atlal4,Hussein Mariam Mohamed1,Alorabi Mohamed1,eldin Nermean Bahie1,Helal Thanaa5,Zaghloul Tarek M6,Venkatesulu Bhanu Prasad7,Elghazaly Hesham1,Al-Sukhun Sana8

Affiliation:

1. Department of Clinical Oncology, Faculty of medicine, Ain Shams University Hospitals, Cairo, 11566, Egypt

2. Biomedical Genomics & Oncogenetics Research Laboratory. Faculty of Sciences and Techniques of Tangier. Abdel Malek Essaadi University, Tangier, 90000, Morocco

3. Department of Radiotherapy, National Cancer Institute, Cairo University, Cairo, 12622, Egypt

4. Department of Medicine, Oncology Division, King Abdulaziz University, Jeddah, 23221, Saudi Arabia

5. Department of Pathology, Ain Shams University Hospitals, Cairo, 11566, Egypt

6. Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, 12622, Egypt

7. Department of Internal Medicine, Henry Ford Hospital, Detroit, MI 48202, USA

8. Al-Hyatt Oncology Center, Faculty of medicine, Jordan University, Amman, 11183, Jordan

Abstract

Breast cancer is the most common malignancy among women worldwide. The current COVID-19 pandemic represents an unprecedented challenge leading to care disruption, which is more severe in low- and middle-income countries (LMIC) due to existing economic obstacles. This review presents the global perspective and preparedness plans for breast cancer continuum of care amid the COVID-19 outbreak and discusses challenges faced by LMIC in implementing these strategies. Prioritization and triage of breast cancer patients in a multidisciplinary team setting are of paramount importance. Deescalation of systemic and radiation therapy can be utilized safely in selected clinical scenarios. The presence of a framework and resource-adapted recommendations exploiting available evidence-based data with judicious personalized use of current resources is essential for breast cancer care in LMIC during the COVID-19 pandemic.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Reference119 articles.

1. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19, 11 March 2020. (Accessed 23 April 2020). https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020

2. World Health Organization. Coronavirus disease (COVID-19) situation reports. (Accessed 23 April 2020). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

3. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

4. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3